BCAL DIAGNOSTICS LIMITED - Announcements

Market Cap $37.65M Add to my watchlist

Healthcare Biotechnology

BCAL Diagnostics Limited is an Australia-based screening and diagnostic company focused... BCAL Diagnostics Limited is an Australia-based screening and diagnostic company focused on early diagnosis of breast cancer. The Company’s core activity is the development of a novel blood screening test to improve the early diagnosis and monitoring of breast cancer, which is available to all women. It is developing diagnostic technology to assist in the early detection of breast cancer by identifying, measuring and validating specific biomarkers enriched in the patient’s blood. It is engaged in the research and development of non-invasive diagnostic technologies designed to complement existing imaging technologies, such as the mammogram. Its BCAL laboratory employs liquid chromatography mass spectrometry (LCMS) platforms to build on the Company's clinical research and leverage progress. The Company’s BCAL test is a lipid biomarker blood (Breast Cancer Associated Lipids test) test with the potential to be used for breast cancer prevention, screening, and monitoring.More

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. WEBINAR: What investors should know about what it takes for ASX-listed companies to get medical developments...

Announcements

Filter Results

All Price Sensitive Only

BDX	Shares and Options Released from Escrow		28/07/23	107.71KB	Share
BDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/07/23	387.47KB	Share
BDX	Shareholder Newsletter		20/07/23	915.58KB	Share
BDX	Notification regarding unquoted securities - BDX		30/06/23	28.08KB	Share
BDX	Proposed issue of securities - BDX		30/06/23	25.57KB	Share
BDX	BCAL Findings Presented at ASCO Annual Meeting		06/06/23	165.54KB	Share
BDX	BCAL Appoints David Darling as Advisor		16/05/23	139.49KB	Share
BDX	Notification regarding unquoted securities - BDX		11/05/23	24.59KB	Share
BDX	Change of Director's Interest Notice		03/05/23	75.41KB	Share
BDX	BCAL Opens Development & Clinical Service Laboratory		03/05/23	79.72KB	Share
BDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	24/04/23	219.05KB	Share
BDX	Half Yearly Report and Accounts	PRICE SENSITIVE	23/02/23	557.69KB	Share
BDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	16/01/23	116.54KB	Share
BDX	Results of Meeting		01/12/22	175.13KB	Share
BDX	Results of Meeting		29/11/22	174.17KB	Share
BDX	BCAL AGM Presentation		29/11/22	1.94MB	Share
BDX	Shareholder Newsletter		16/11/22	2.67MB	Share
BDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/22	135.99KB	Share
BDX	Letter to Shareholders on Annual General Meeting Notice		28/10/22	177.75KB	Share
BDX	Notice of Annual General Meeting/Proxy Form		28/10/22	723.77KB	Share
BDX	Establishment of Development & Clinical Service Laboratory		25/10/22	45.09KB	Share
BDX	Appendix 4G and Corporate Governance Statement		29/09/22	272.35KB	Share
BDX	Annual Report to shareholders		29/09/22	1.22MB	Share
BDX	Preliminary Final Report	PRICE SENSITIVE	30/08/22	380.59KB	Share
BDX	Application for quotation of securities - BDX		29/08/22	24.76KB	Share
BDX	Proposed issue of securities - BDX		25/08/22	24.73KB	Share
BDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/22	111.26KB	Share
BDX	Change of Director's Interest Notice		04/07/22	78.84KB	Share
BDX	BCAL Enters US Product Development Agreement with Precion	PRICE SENSITIVE	28/06/22	50.05KB	Share
BDX	Change in substantial holding		27/06/22	257.77KB	Share
BDX	BCAL Presentation Accepted for 2022 ASCO Annual Meeting		01/06/22	38.53KB	Share
BDX	Application for quotation of securities - BDX		03/05/22	24.88KB	Share
BDX	BCAL to Present at NWR Virtual Investor Conference		02/05/22	37.7KB	Share
BDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/22	189.47KB	Share
BDX	Shareholder Newsletter		24/03/22	326.25KB	Share
BDX	Change of Director's Interest Notice		02/03/22	75.45KB	Share
BDX	Appendix 4D & Interim Report	PRICE SENSITIVE	18/02/22	830.8KB	Share
BDX	Shares to be released from escrow		14/02/22	45.35KB	Share
BDX	7 February Announcement - Additional Information	PRICE SENSITIVE	08/02/22	103.11KB	Share
BDX	Recent Analysis Significantly Improves Commercial Prospects	PRICE SENSITIVE	07/02/22	48.81KB	Share
BDX	Appendix 4C Revised		04/02/22	92.74KB	Share
BDX	Becoming a substantial holder		31/01/22	202.08KB	Share
BDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/01/22	113.43KB	Share
BDX	Dr John Hurrell Appointed Chief Executive Officer	PRICE SENSITIVE	11/01/22	50.17KB	Share
BDX	Application for quotation of securities - BDX		29/12/21	25.29KB	Share
BDX	Change In Directors Interest Notice - Correction		13/12/21	78.7KB	Share
BDX	Directors Change of Interest Notice X 2		13/12/21	73.41KB	Share
BDX	Results of Meeting		23/11/21	106.33KB	Share
BDX	Results of Meeting		22/11/21	104.99KB	Share
BDX	AGM Presentation		22/11/21	4.1MB	Share
BDX	Addendum to Appendix 4C		08/11/21	132.61KB	Share
BDX	Strong Cohort 4 Testing Data Demonstrates Value of BCAL Test	PRICE SENSITIVE	03/11/21	185.43KB	Share
BDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/10/21	233.3KB	Share
BDX	Ceasing to be a substantial holder		26/10/21	81.62KB	Share
BDX	letter to Shareholders AGM Notice		21/10/21	183.36KB	Share
BDX	Notice of Annual General Meeting/Proxy Form		21/10/21	534.61KB	Share
BDX	AGM Date and Closing Date for Director Nominations		04/10/21	144.85KB	Share
BDX	Appendix 4G and Corporate Governance Statement		28/09/21	578.08KB	Share
BDX	Annual Report to shareholders		28/09/21	1.93MB	Share
BDX	Change of Director's Interest Notice		13/09/21	213.42KB	Share
BDX	Change of Director's Interest Notice		07/09/21	213.13KB	Share
BDX	Australian Clinical Studies Launched	PRICE SENSITIVE	03/09/21	137.38KB	Share
BDX	Preliminary Final Report	PRICE SENSITIVE	31/08/21	463.84KB	Share
BDX	Market Update	PRICE SENSITIVE	17/08/21	167.62KB	Share
BDX	Becoming a substantial holder		22/07/21	85.02KB	Share
BDX	BCAL Diagnostics to List on ASX After Raising $10m in IPO		21/07/21	164.1KB	Share
BDX	BCAL Diagnostics Investor Presentation		21/07/21	2.01MB	Share
BDX	Initial Directors Interest Notice X 5		21/07/21	509.71KB	Share
BDX	Initial Substantial Shareholder Notice X 4		21/07/21	1.21MB	Share
BDX	Pre-Quotation Disclosure		19/07/21	113.9KB	Share
BDX	Top 20 Holders		19/07/21	74.31KB	Share
BDX	Distribution Schedule		19/07/21	63.35KB	Share
BDX	Securities Trading Policy		19/07/21	100.65KB	Share
BDX	Equity Incentive Plan Rules		19/07/21	289.31KB	Share
BDX	Terms & Conditions of Options		19/07/21	157.25KB	Share
BDX	Interim Report 31 December 2020		19/07/21	750.62KB	Share
BDX	Annual Report 30 June 2020		19/07/21	856.05KB	Share
BDX	Annual Report 30 June 2019		19/07/21	786.41KB	Share
BDX	Constitution		19/07/21	709.71KB	Share
BDX	Prospectus		19/07/21	5.2MB	Share
BDX	Appendix 1A and Information Form and Checklist		19/07/21	447.19KB	Share
BDX	ASX Market Release - Admission and Quotation		19/07/21	451.2KB	Share

BDX Shares and Options Released from Escrow
28/07/23		107.71KB	Share
BDX Quarterly Activities/Appendix 4C Cash Flow Report
27/07/23	PRICE SENSITIVE	387.47KB	Share
BDX Shareholder Newsletter
20/07/23		915.58KB	Share
BDX Notification regarding unquoted securities - BDX
30/06/23		28.08KB	Share
BDX Proposed issue of securities - BDX
30/06/23		25.57KB	Share
BDX BCAL Findings Presented at ASCO Annual Meeting
06/06/23		165.54KB	Share
BDX BCAL Appoints David Darling as Advisor
16/05/23		139.49KB	Share
BDX Notification regarding unquoted securities - BDX
11/05/23		24.59KB	Share
BDX Change of Director's Interest Notice
03/05/23		75.41KB	Share
BDX BCAL Opens Development & Clinical Service Laboratory
03/05/23		79.72KB	Share
BDX Quarterly Activities/Appendix 4C Cash Flow Report
24/04/23	PRICE SENSITIVE	219.05KB	Share
BDX Half Yearly Report and Accounts
23/02/23	PRICE SENSITIVE	557.69KB	Share
BDX Quarterly Activities/Appendix 4C Cash Flow Report
16/01/23	PRICE SENSITIVE	116.54KB	Share
BDX Results of Meeting
01/12/22		175.13KB	Share
BDX Results of Meeting
29/11/22		174.17KB	Share
BDX BCAL AGM Presentation
29/11/22		1.94MB	Share
BDX Shareholder Newsletter
16/11/22		2.67MB	Share
BDX Quarterly Activities/Appendix 4C Cash Flow Report
31/10/22	PRICE SENSITIVE	135.99KB	Share
BDX Letter to Shareholders on Annual General Meeting Notice
28/10/22		177.75KB	Share
BDX Notice of Annual General Meeting/Proxy Form
28/10/22		723.77KB	Share
BDX Establishment of Development & Clinical Service Laboratory
25/10/22		45.09KB	Share
BDX Appendix 4G and Corporate Governance Statement
29/09/22		272.35KB	Share
BDX Annual Report to shareholders
29/09/22		1.22MB	Share
BDX Preliminary Final Report
30/08/22	PRICE SENSITIVE	380.59KB	Share
BDX Application for quotation of securities - BDX
29/08/22		24.76KB	Share
BDX Proposed issue of securities - BDX
25/08/22		24.73KB	Share
BDX Quarterly Activities/Appendix 4C Cash Flow Report
28/07/22	PRICE SENSITIVE	111.26KB	Share
BDX Change of Director's Interest Notice
04/07/22		78.84KB	Share
BDX BCAL Enters US Product Development Agreement with Precion
28/06/22	PRICE SENSITIVE	50.05KB	Share
BDX Change in substantial holding
27/06/22		257.77KB	Share
BDX BCAL Presentation Accepted for 2022 ASCO Annual Meeting
01/06/22		38.53KB	Share
BDX Application for quotation of securities - BDX
03/05/22		24.88KB	Share
BDX BCAL to Present at NWR Virtual Investor Conference
02/05/22		37.7KB	Share
BDX Quarterly Activities/Appendix 4C Cash Flow Report
28/04/22	PRICE SENSITIVE	189.47KB	Share
BDX Shareholder Newsletter
24/03/22		326.25KB	Share
BDX Change of Director's Interest Notice
02/03/22		75.45KB	Share
BDX Appendix 4D & Interim Report
18/02/22	PRICE SENSITIVE	830.8KB	Share
BDX Shares to be released from escrow
14/02/22		45.35KB	Share
BDX 7 February Announcement - Additional Information
08/02/22	PRICE SENSITIVE	103.11KB	Share
BDX Recent Analysis Significantly Improves Commercial Prospects
07/02/22	PRICE SENSITIVE	48.81KB	Share
BDX Appendix 4C Revised
04/02/22		92.74KB	Share
BDX Becoming a substantial holder
31/01/22		202.08KB	Share
BDX Quarterly Activities/Appendix 4C Cash Flow Report
27/01/22	PRICE SENSITIVE	113.43KB	Share
BDX Dr John Hurrell Appointed Chief Executive Officer
11/01/22	PRICE SENSITIVE	50.17KB	Share
BDX Application for quotation of securities - BDX
29/12/21		25.29KB	Share
BDX Change In Directors Interest Notice - Correction
13/12/21		78.7KB	Share
BDX Directors Change of Interest Notice X 2
13/12/21		73.41KB	Share
BDX Results of Meeting
23/11/21		106.33KB	Share
BDX Results of Meeting
22/11/21		104.99KB	Share
BDX AGM Presentation
22/11/21		4.1MB	Share
BDX Addendum to Appendix 4C
08/11/21		132.61KB	Share
BDX Strong Cohort 4 Testing Data Demonstrates Value of BCAL Test
03/11/21	PRICE SENSITIVE	185.43KB	Share
BDX Quarterly Activities/Appendix 4C Cash Flow Report
28/10/21	PRICE SENSITIVE	233.3KB	Share
BDX Ceasing to be a substantial holder
26/10/21		81.62KB	Share
BDX letter to Shareholders AGM Notice
21/10/21		183.36KB	Share
BDX Notice of Annual General Meeting/Proxy Form
21/10/21		534.61KB	Share
BDX AGM Date and Closing Date for Director Nominations
04/10/21		144.85KB	Share
BDX Appendix 4G and Corporate Governance Statement
28/09/21		578.08KB	Share
BDX Annual Report to shareholders
28/09/21		1.93MB	Share
BDX Change of Director's Interest Notice
13/09/21		213.42KB	Share
BDX Change of Director's Interest Notice
07/09/21		213.13KB	Share
BDX Australian Clinical Studies Launched
03/09/21	PRICE SENSITIVE	137.38KB	Share
BDX Preliminary Final Report
31/08/21	PRICE SENSITIVE	463.84KB	Share
BDX Market Update
17/08/21	PRICE SENSITIVE	167.62KB	Share
BDX Becoming a substantial holder
22/07/21		85.02KB	Share
BDX BCAL Diagnostics to List on ASX After Raising $10m in IPO
21/07/21		164.1KB	Share
BDX BCAL Diagnostics Investor Presentation
21/07/21		2.01MB	Share
BDX Initial Directors Interest Notice X 5
21/07/21		509.71KB	Share
BDX Initial Substantial Shareholder Notice X 4
21/07/21		1.21MB	Share
BDX Pre-Quotation Disclosure
19/07/21		113.9KB	Share
BDX Top 20 Holders
19/07/21		74.31KB	Share
BDX Distribution Schedule
19/07/21		63.35KB	Share
BDX Securities Trading Policy
19/07/21		100.65KB	Share
BDX Equity Incentive Plan Rules
19/07/21		289.31KB	Share
BDX Terms & Conditions of Options
19/07/21		157.25KB	Share
BDX Interim Report 31 December 2020
19/07/21		750.62KB	Share
BDX Annual Report 30 June 2020
19/07/21		856.05KB	Share
BDX Annual Report 30 June 2019
19/07/21		786.41KB	Share
BDX Constitution
19/07/21		709.71KB	Share
BDX Prospectus
19/07/21		5.2MB	Share
BDX Appendix 1A and Information Form and Checklist
19/07/21		447.19KB	Share
BDX ASX Market Release - Admission and Quotation
19/07/21		451.2KB	Share

REFRESH

First

(20min delay)
Last 10.5¢		Change -0.005(4.55%)		Mkt cap ! $37.65M

Open	High	Low	Value	Volume
10.5¢	10.5¢	10.5¢	$44.92K	427.8K

Buyers (Bids)

No.	Vol.	Price($)
5	1039738	10.0¢

Sellers (Offers)

Price($)	Vol.	No.
10.5¢	10525	1

View Market Depth

No.	Vol.	Price($)
5	1039738	0.100
1	20000	0.099
1	10309	0.097
1	50000	0.096
2	125000	0.095

Price($)	Vol.	No.
0.105	10525	1
0.110	322000	3
0.115	692634	5
0.120	358467	7
0.125	141660	2

Last trade - 12.53pm 15/11/2024 (20 minute delay)


Last 10.5¢		Change -0.005 ( 0.00 %)
Open	High	Low	Volume
10.5¢	10.5¢	10.5¢	315691
Last updated 13.04pm 15/11/2024 ?

BDX (ASX) Chart

BCAL DIAGNOSTICS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories